Demo-Video-Interaction-The Selection of Biologics: No Easy Task Video

The Selection of Biologics: No Easy Task Video

Video Transcription

Video Summary

In this video, Dr. Sandy Corona from the University of Rochester discusses the selection of biologics for asthma treatment. She presents a case of a 45-year-old woman with poorly controlled asthma and explores factors to consider when choosing a biologic. Dr. Corona discusses the available options, including omalizumab, mepolizumab, benralizumab, reslizumab, and dupilumab. She highlights their mechanisms of action, dosing, administration methods, and potential side effects. Dr. Corona emphasizes the importance of monitoring treatment response and considering factors such as comorbidities and patient preferences when selecting a biologic. She concludes by discussing the lack of comparative evidence and the need for ongoing assessment in patients on biologic therapy.

Keywords

biologics

asthma treatment

Dr. Sandy Corona

selection factors

available options